|
1
|
Badiee P and Hashemizadeh Z: Opportunistic
invasive fungal infections: Diagnosis & clinical management.
Indian J Med Res. 139:195–204. 2014.PubMed/NCBI
|
|
2
|
Ribes JA, Vanover-Sams CL and Baker DJ:
Zygomycetes in human disease. Clin Microbiol Rev. 13:236–301. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Baddley JW: Clinical risk factors for
invasive aspergillosis. Med Mycol. 49 Suppl 1:S7–S12. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Badiee P, Alborzi A and Farhoudi F: A case
of Candida mediastinitis after dental extraction. J Infect
Dev Ctries. 5:75–78. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Vandewoude KH, Blot SI, Depuydt P, Benoit
D, Temmerman W, Colardyn F and Vogelaers D: Clinical relevance of
Aspergillus isolation from respiratory tract samples in
critically ill patients. Crit Care. 10:R312006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Garnacho-Montero J, Amaya-Villar R,
Ortiz-Leyba C, León C, Alvarez-Lerma F, Nolla-Salas J,
Iruretagoyena JR and Barcenilla F: Isolation of Aspergillus
spp. from the respiratory tract in critically ill patients: Risk
factors, clinical presentation and outcome. Crit Care. 9:R191–R199.
2005. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cornillet A, Camus C, Nimubona S, Gandemer
V, Tattevin P, Belleguic C, Chevrier S, Meunier C, Lebert C, Aupée
M, et al: Comparison of epidemiological, clinical, and biological
features of invasive aspergillosis in neutropenic and
nonneutropenic patients: A 6-year survey. Clin Infect Dis.
43:577–584. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Georgiadou SP, Sipsas NV, Marom EM and
Kontoyiannis DP: The diagnostic value of halo and reversed halo
signs for invasive mold infections in compromised hosts. Clin
Infect Dis. 52:1144–1155. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bruno C, Minniti S, Vassanelli A and
Pozzi-Mucelli R: Comparison of CT features of Aspergillus
and bacterial pneumonia in severely neutropenic patients. J Thorac
Imaging. 22:160–165. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Escuissato DL, Gasparetto EL, Marchiori E,
Rocha GM, Inoue C, Pasquini R and Müller NL: Pulmonary infections
after bone marrow transplantation: high-resolution CT findings in
111 patients. AJR Am J Roentgenol. 185:608–615. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hope WW, Walsh TJ and Denning DW:
Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis.
5:609–622. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yeo SF and Wong B: Current status of
nonculture methods for diagnosis of invasive fungal infections.
Clin Microbiol Rev. 15:465–484. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ma SH, Xu K, Xiao ZW, Wu M, Sun ZY, Wang
ZX, Hu ZG, Dai X, Han MJ and Li YG: Peripheral lung cancer:
Relationship between multi-slice spiral CT perfusion imaging and
tumor angiogenesis and cyclin D1 expression. Clin Imaging.
31:165–177. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Caillot D, Couaillier JF, Bernard A,
Casasnovas O, Denning DW, Mannone L, Lopez J, Couillault G, Piard
F, Vagner O, et al: Increasing volume and changing characteristics
of invasive pulmonary aspergillosis on sequential thoracic computed
tomography scans in patients with neutropenia. J Clin Oncol.
19:253–259. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fuchs T, Kachelriess M and Kalender WA:
Technical advances in multi-slice spiral CT. Eur J Radiol.
36:69–73. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang WL, Cao J, Chen BY, Xie W, Dong LX,
Wu YQ, Li JN and Hu ZD: A preliminary study on the measurement of
(1,3)-β-D-glucan in bronchoalveolar lavage for the diagnosis of
pulmonary fungal infections. Zhonghua Jie He He Hu Xi Za Zhi.
35:897–900. 2012.(In Chinese). PubMed/NCBI
|
|
17
|
Lin SJ, Schranz J and Teutsch SM:
Aspergillosis case - fatality rate: Systematic review of the
literature. Clin Infect Dis. 32:358–366. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Segal BH and Walsh TJ: Current approaches
to diagnosis and treatment of invasive aspergillosis. Am J Respir
Crit Care Med. 173:707–717. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Patterson TF: Advances and challenges in
management of invasive mycoses. Lancet. 366:1013–1025. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Prasad A, Agarwal K, Deepak D and Atwal
SS: Pulmonary Aspergillosis: What CT can offer before it is too
late! J Clin Diagn Res. 10:TE01–TE05. 2016.PubMed/NCBI
|
|
21
|
Christe A, Lin MC, Yen AC, Hallett RL,
Roychoudhury K, Schmitzberger F, Fleischmann D, Leung AN, Rubin GD,
Vock P, et al: CT patterns of fungal pulmonary infections of the
lung: Comparison of standard-dose and simulated low-dose CT. Eur J
Radiol. 81:2860–2866. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Park SY, Kim SH, Choi SH, Sung H, Kim MN,
Woo JH, Kim YS, Park SK, Lee JH, Lee KH, et al: Clinical and
radiological features of invasive pulmonary aspergillosis in
transplant recipients and neutropenic patients. Transpl Infect Dis.
12:309–315. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Franquet T, Müller NL, Giménez A, Guembe
P, de La Torre J and Bagué S: Spectrum of pulmonary aspergillosis:
Histologic, clinical, and radiologic findings. Radiographics.
21:825–837. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Paulussen C, Hallsworth JE, Álvarez-Pérez
S, Nierman WC, Hamill PG, Blain D, Rediers H and Lievens B: Ecology
of aspergillosis: Insights into the pathogenic potency of
Aspergillus fumigatus and some other Aspergillus
species. Microb Biotechnol. 10:296–322. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Demirkazik FB, Akin A, Uzun O, Akpinar MG
and Ariyürek MO: CT findings in immunocompromised patients with
pulmonary infections. Diagn Interv Radiol. 14:75–82.
2008.PubMed/NCBI
|
|
26
|
De Pauw B, Walsh TJ, Donnelly JP, Stevens
DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O,
Kauffman CA, et al: European Organization for Research and
Treatment of Cancer/Invasive Fungal Infections Cooperative Group;
National Institute of Allergy and Infectious Diseases Mycoses Study
Group (EORTC/MSG) Consensus Group: Revised definitions of invasive
fungal disease from the European Organization for Research and
Treatment of Cancer/Invasive Fungal Infections Cooperative Group
and the National Institute of Allergy and Infectious Diseases
Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis.
46:1813–1821. 2008. View
Article : Google Scholar : PubMed/NCBI
|
